ziltivekimab
Showing 1 - 5 of 5
Cardiovascular Risk, Acute Myocardial Infarction (AMI) Trial in India (Ziltivekimab, Placebo)
Not yet recruiting
- Cardiovascular Risk
- Acute Myocardial Infarction (AMI)
- Ziltivekimab
- Placebo
-
New Delhi, Delhi, India
- +12 more
Nov 8, 2023
Chronic Kidney Disease and Systemic Inflammation Trial in Beijing (Ziltivekimab, Placebo)
Active, not recruiting
- Chronic Kidney Disease and Systemic Inflammation
- Ziltivekimab
- Placebo
-
Beijing, Beijing, China
- +3 more
Nov 10, 2022
Chronic Kidney Disease, Inflammation, Cardiovascular Risk Trial in Ehime (Ziltivekimab, Placebo (ziltivekimab))
Completed
- Chronic Kidney Disease
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Ehime, JapanNovo Nordisk Investigational Site
Oct 26, 2021
Heart Failure Trial in Worldwide (Ziltivekimab, Placebo)
Not yet recruiting
- Heart Failure
- Ziltivekimab
- Placebo
-
Alexander City, Alabama
- +420 more
Dec 23, 2022
Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))
Recruiting
- Cardiovascular Risk
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Birmingham, Alabama
- +768 more
Dec 23, 2022